Executive summary

Continued clinical cancer care during the Covid-19 pandemic

Researchers at the Antwerp University Hospital published their findings of using Remecare’s tele-monitoring solution to continue oncologic care during the pandemic in the British Journal of Oncology.

Read the summary

Leading hospitals use Remecare

"Thanks to Remecare we can differentiate whether symptoms should lead to a hospital visit or not."

Prof. Dr. Marc Peeters
CEO, UZA

"Remecare gives us a sense of security. We know if patients are therapy compliant and we can avoid emergencies or unexpected consultations."

Prof. Dr. Christof Vulsteke
Head of department Oncology AZ Maria Middelares

“Remecare has revolutionized patient monitoring for our hospital. It has greatly improved our ability to track transmural IV antibiotic treatments and provide timely care.”

Dr. Vincent Verschaeve
Oncologist, GHDC

Maximizing return-on-care for clinical teams

Remecare is already available for an array of different care pathways. Schedule a demo below and start embracing a return-on-care built on top of Remecare today.

Schedule a demo